Promega Contributing to the prevention, healing and more. Founded in 1978, which began with the production of enzymes for research, has evolved into a catalog of over 2,000 products for a wide range of applications, including basic research, drug discovery, forensics, paternity testing and diagnosis clinician.

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

Kikkoman Corp. is a holding company which engages in the food manufacturing business. It operates through the following segments: Domestic Foods-Manufacturing and Sales, Domestic Others, Overseas Foods-Manufacturing and Sales, and Overseas Foods-Wholesale. The Domestic Foods-Manufacturing and Sales segment manufactures and sells soy sauce, beverages, and alcoholic beverages. The Domestic Others segment involves in the production and sale of clinical diagnostic reagents, hygiene inspection agents, processing enzymes and chemical products such as hyaluronic acid. It also operates in real estate property leasing, logistics, and back-office support for Kikkoman Group, and other businesses. The Overseas Foods-Manufacturing and Sales segment sells soy sauce, Del Monte products, and overseas health foods. The Overseas Food-Wholesale segment purchases and sells oriental food products in Japan and overseas. The company was founded on December 7, 1917 and is headquartered in Noda, Japan.

Toyobo Co., Ltd. engages in the manufacture, processing, and sale of specialty and functional products. It operates through the following segments: Films and Functional Materials, Mobility, Life and Environment, Life Science, Real Estate, and Others The Films and Functional Materials segment includes manufacturing and sales of packaging films, industrial films, industrial adhesives, and optical functional materials. The Mobility segment handles the manufacture and sale of engineering plastics and airbag fabrics. The Life and Environment segment covers the manufacture and sales of aqua membranes, functional filters, super fibers, non-woven fabrics, functional clothing, apparel products, clothing textiles, and clothing fibers, The Life Science segment manufactures and sells bio-products such as enzymes for diagnostic reagents, pharmaceuticals, medical membranes, and medical equipment, The Real Estate segment engages in the leasing and management of real estate. The Others segment includes building design and construction, and information processing and logistic services. The company was founded by Eiichi Shibusawa on May 3, 1882 and is headquartered in Osaka, Japan.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Prolume is a biotechnology company whose core business is based upon newly discovered genes from deep water marine bioluminescent organisms. This has broad applications for biomedical research, drug discovery, and entertainment.

Secretary of State for Defence is a private company headquartered in the United Kingdom with subsidiaries in that country. The firm operates as a state secretary of defense.

Gene Stream Pty Ltd is a privately owned biotechnology company, founded in Perth, Western Australia. Their focus is the development and provision of gene-based research tools that stream-line drug discovery. Their missions are to develop, patent and market improved DNA-based research tools, particularly for use in drug discovery and development, and to provide the pharmaceutical industry with enhanced technologies that improve the accuracy and cost-effectiveness of drug discovery programs.

Xenogen Corporation is a biotechnology company offering an integrated suite of biophotonic real-time in vivo imaging and genetic modification technologies that can help expedite drug discovery and development, and significantly reduce the cost and time to market for new therapies. Xenogen's VivoVision(TM) Systems non-invasively illuminate and monitor biological processes within living mammals, at the molecular level, in real time. The technology is designed to provide higher quality in vivo data earlier in the drug discovery and development process. VivoVision(TM) Solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. VivoVision(TM) Biosciences represents more than 15 years of experience in the creation and characterization of animal models, including genetic modifications, comprehensive phenotyping, compound profiling and custom design and production of light producing cells, microorganisms and animals.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Toyo Ink SC Holdings Co., Ltd. engages in the strategic planning and management of its group companies. Its operations are carried out through the following business segments: Colorants and Functional Materials, Polymers and Coatings, Packaging Materials, Printing and Information, and Others. The Colorants and Functional Materials segment offers organic pigments, processed pigments, plastic colorants, and materials for color filters. The Polymers and Coatings segment produces and markets can paints, resins, adhesives, coating materials, natural extracts, and medical products. The Packaging Materials segment deals with gravure inks, flexo inks, and gravure cylinder making systems. The Printing and Information segment manufactures and sells offset inks, metal decorative inks, printers, printing materials, and prepress. The Others segment includes provision of services and sale of raw materials. The company was founded by Kamataro Kobayashi in January 1896 and is headquartered in Tokyo, Japan.

A peloton is a team of bicyclists who achieve great efficiency of motion through cooperative action. It is also the root of platoon, a nimble military unit with capabilities that exceed the sum of its component parts. Founded by Chairman of Biochemistry Steven L. McKnight of UT Southwestern Medical Center, Peloton Therapeutics represents a unique combination of innovative science, strong financial support from the Cancer Prevention Research Institute of Texas (CPRIT), and seasoned investors and management. Working in close collaboration with scientists at UT Southwestern, Peloton is advancing a promising discovery and development pipeline, comprised of several small molecule-based programs, each with a distinct target and mechanism of action. Peloton's vision is to become a major biotech company in Dallas with a passion for discovering and developing novel cancer drugs.

The Institut national de la recherche agronomique (INRA, pronounced [inʁa]; English: National Institute of Agricultural Research) is a French public research institute dedicated to agricultural science. It was founded in 1946 and is a Public Scientific and Technical Research Establishment under the joint authority of the Ministries of Research and Agriculture.

CardioGenics, Inc. manufactures biotechnology and medical devices. It develops in-vitro-diagnostics cardiac testing products. The company was founded in 1997 and is headquartered in Mississauga, Canada.

Diagnostic HYBRIDS, Inc. develops, manufactures, and markets cellular and molecular diagnostic kits for various applications in detecting a range of respiratory diseases, herpes infections, thyroid function, and other markers of diseases. The company offers D3 FastPoint L-DFA influenza A/influenza B virus identification kit, which allows for the identification of influenza A virus and influenza B virus from a patient's specimen in under 30 minutes. It also develops and commercializes genetically engineered cell-based detection products for the pharmaceutical and biotechnology industry with a focus on pharmacology assays and products that measure drug clearance and anti-viral interventions with drugs and vaccines. In addition, the company provides an assortment of products for specimen collection, specimen transport, multi-virus cell culture amplification, and sensitive and specific virus detection using monoclonal antibody kits and reagents. Further, it offers respiratory, herpes family, chlamydia, and enterovirus testing solutions; monolayer cell line products for use in diagnosing and detecting viruses that cause human illness; C. difficile toxin; flocked swabs and UTM; and media and supplements, including prepared media, salt solutions, antibiotic solutions, and trypsin solutions. Furthermore, the company provides products and services for non-diagnostic applications, including in vitro toxicology and metabolism products and services, such as primary hepatocytes and hepatocyte-based assays. It also supports educational programs for influenza A, influenza B, RSV, MPV, Adenovirus, and Parainfluenza 1, 2, and 3 through direct speaker programs and educational grants, as well as Internet-based education programs. The company was formerly known as Molecular Diagnostics, Inc. Diagnostic HYBRIDS, Inc. was founded in 1983 and is based in Athens, Ohio.

Manufactures pharmaceuticals and diagnostic substances

Korea Institute of Radiological & Medical Sciences specializes in radiation technology, research, development, genomics, and radiotherapy.

Chisso Corp. engages in the manufacture and sale of chemical products. It offers liquid crystals, polyolefin composite fibers, coated fertilizers, and chemical fertilizers. The company was founded on January 12, 1906 and is headquartered in Tokyo, Japan.